Adenocarcinoma of the Pancreas Completed Phase 2 Trials for Irinotecan (DB00762)

Also known as: Pancreatic adenocarcinoma / Adenocarcinoma Pancreas / Pancreas, Adenocarcinoma / Pancreas Adenocarcinoma / Adenocarcinoma of Pancreas / Adenocarcinoma, Pancreas

IndicationStatusPhase
DBCOND0029532 (Adenocarcinoma of the Pancreas)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01660711A Pilot Study of Pre- and Post-surgery Chemotherapy With mFOLFIRINOX in Localized, Resectable Pancreatic AdenocarcinomaTreatment
NCT01558869Xeloxiri as First-line Treatment in Patients With Advanced Unresectable Pancreatic AdenocarcinomaTreatment